{"id":"W4200318327","doi":"10.1136/annrheumdis-2021-221019","title":"Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 1 trial","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":143,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Psoriatic arthritis; Double blind; Internal medicine; Psoriasis; Physical therapy; Arthritis; Dermatology; Alternative medicine; Placebo; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005029969,0.001731792,0.005616283,0.0005707932,0.0007136899,0.001505403,0.001121167,0.003153628,0.004244635],"category_scores_gemma":[0.004056551,0.000891317,0.002644744,0.0004244063,0.002041379,0.001631237,0.0005362973,0.003305745,0.001186858],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007028831,"about_ca_system_score_gemma":0.001306596,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003892729,"about_ca_topic_score_gemma":0.0008156379,"domain_scores_codex":[0.9977912,0.001256503,0.0001508873,0.0003090672,0.0002133181,0.0002789879],"domain_scores_gemma":[0.9975423,0.0008926871,0.0006172836,0.0003410216,0.0001767753,0.0004299425],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9510782,0.01405975,0.000492315,0.0007034281,0.0007241543,0.00005753981,0.0000789835,0.0006066075,0.009141969,0.00006547913,0.000596931,0.02239457],"study_design_scores_gemma":[0.6981316,0.2936387,0.003265279,0.00004828695,0.0006173596,0.00008879441,0.00003602705,0.0007848734,0.002364341,0.0002098642,0.0007619493,0.00005289869],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9842792,0.006365804,0.002013942,0.0004233152,0.0004431899,0.004066414,0.001023883,0.0003331415,0.001051158],"genre_scores_gemma":[0.9818715,0.003302095,0.004439418,0.001102993,0.0006499717,0.005278927,0.0007484562,0.00008567269,0.002520829],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005616283,"threshold_uncertainty_score":0.02660137,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08568492154785824,"score_gpt":0.3542474489658146,"score_spread":0.2685625274179563,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}